Carol Brosgart

Carol L.
Brosgart is the founder of East Bay AIDS Center, which was founded in 1987.
She served as the Medical Director from 1987 to 1988.
Dr. Brosgart currently holds several positions, including Independent Director at Renovaro, Inc. since 2019, Director at American Liver Foundation of Northern California, Director & Research Integrity Officer at Hepatitis B Foundation, Independent Director at Galmed Pharmaceuticals Ltd.
since 2017, Independent Director at Abivax SA since 2018, Director at A.P.
Giannini Foundation, Director at Berkeley Community Fund, Director at Pure Blue Diagnostics, Inc., Director at National Viral Hepatitis Roundtable, Director at MERLIN Biotech LLC starting in 2022, Professor at The University of California, San Francisco, and Research Integrity Officer at Baruch S.
Blumberg Institute.
Dr. Brosgart has held former positions as Director at Juvaris BioTherapeutics, Inc., Director at The San Francisco Aids Foundation, Independent Director at Tobira Therapeutics, Inc. from 2009 to 2016, Medical Director at Central Health Center, Independent Director at Mirum Pharmaceuticals, Inc. from 2021 to 2022, Director at Pangaea Global Aids, Director at Intrivo Diagnostics, Medical Director at Alameda County Health Care Services Agency from 1978 to 1987, Vice President-Public Health & Policy at Gilead Sciences, Inc. from 1998 to 2009, Chief Medical Officer at Alios BioPharma, Inc. in 2011, and Chief Medical Officer & Senior Vice President at Children's Hospital Oakland Research Institute from 2009 to 2011.
Dr. Brosgart's education includes an undergraduate degree from the University of California, Berkeley and a doctorate degree from the University of California, San Francisco.